The serum Gal-3 level in the NSTE-ACS group was higher than those in the stable CAD group, 4.72 (1.0–16.14) vs. 2.23 (0.65–23.8) ng/ml, P = 0.04. The gene discussed is LGALS3; the disease is coronary artery disorder.